Pharma News

Mitochondrial diseases caused by POLG mutations vary in severity. In young children, these diseases can quickly result in brain damage and life-threatening liver problems while others suffer muscle weakness, epilepsy, and organ failure later in childhood. POLG mutations recently received media attention when Prince Frederik of Nassau in Luxembourg died in March 2025 at just 22 years of age.

Pacira BioSciences, Inc. the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced that it has settled its litigations with Fresenius Kabi USA, LLC Fresenius, Jiangsu Hengrui Pharmaceuticals Co., Ltd

The State Key Laboratory for Emerging Infectious Diseases at the University of Hong Kong and the InnoHK Centre for Virology, Vaccinology and Therapeutics have pioneered an influenza virus vector-based nasal spray vaccine platform and developed a nasal spray H5N1 avian influenza vaccine.

Two undergraduate medicine students at University of Galway have led a major study examining how cardioprotective glucose-lowering therapies - medications that lower blood sugar and reduce the risk of heart disease in people with diabetes - affect the risk of developing dementia.

The Karnataka state government has terminated the Karnataka State Pharmacy Council (KSPC) and entrusted an administrator with its responsibilities. The decision was taken after several complaints and a detailed government inquiry exposed serious irregularities, misuse of power, and failure to conduct timely elections.

A new study led by the University of Southampton has found that medications for ADHD have overall small effects on blood pressure and heart rate after weeks or a few months of use. There have been concerns about the side effects of ADHD medications but the new findings, coupled with other studies, suggest that the benefits of taking these medications outweigh the risks, while highlighting the need for careful monitoring.

Nearly one million people worldwide are plagued annually by cutaneous leishmaniasis, a devastating skin infection caused by the Leishmania parasite. Predominantly affecting vulnerable populations in tropical and subtropical regions like North Africa and South America, this disease thrives in areas marked by malnutrition, poor housing and population displacement.

Drug-resistant infections especially from deadly bacteria like tuberculosis and staph are a growing global health crisis. These infections are harder to treat, often require more expensive or toxic medications and are responsible for longer hospital stays and higher mortality rates.

In people with this disease, small fibres of TTR protein clump together to make deposits called amyloid. Amyloid can build up around or within the nerves, heart and other organs, stopping them from working properly. Eplontersen is specifically indicated for use when the disease is causing polyneuropathy, which is damage to multiple nerves outside of the brain and central nervous system, resulting in pain, discomfort, progressive weakness and loss of sensation in the legs and arms, and mobility difficulties.